TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive Also in this 8-page issue: NCI advisors approve $15-million set-aside for laboratory testing on “reduced harm” tobacco products. July 9, 2004
TCL Archive ASCO Publishes Guidelines For Dosing Chemotherapy Correctly in Obese Patients April 27, 2012
TCL Archive In Brief: Salmon To Step Down As Center Director; Becker To Relinquish Positions At MDACC September 4, 1998
